Oncolytic Hairpin DNA Pair: Selective Cytotoxic Inducer through MicroRNA-Triggered DNA Self-Assembly

Area of Science:

• Biotechnology
• Immunology
• Oncology

Background:

• Artificial nucleic acids show promise for cancer immunotherapy by activating innate immune responses.
• Current limitations include poor cancer cell selectivity, leading to systemic immunotoxicity.
• Developing targeted delivery systems is crucial for effective artificial nucleic acid-based cancer therapies.

Purpose of the Study:

• To develop a novel hairpin DNA assembly technology for cancer-selective immune activation.
• To engineer artificial DNA that self-assembles into cytotoxic agents within cancer cells.
• To overcome the challenge of systemic immunotoxicity in artificial nucleic acid cancer therapy.

Main Methods:

• Designed artificial DNA hairpins that self-assemble into nicked double-stranded DNA.
• Utilized intracellular microRNA-21 (miR-21) as a trigger for DNA assembly, as miR-21 is overexpressed in many cancers.
• Evaluated the selective cytotoxicity of the assembled DNA in cancer cells in vitro and in vivo.

Main Results:

• The hairpin DNA assembly technology demonstrated cancer-selective immune activation.
• The self-assembled DNA products selectively killed miR-21-abundant cancer cells.
• Successful in vitro and in vivo eradication of cancer cells was observed, mediated by innate immune activation.

Conclusions:

• This study presents the first approach for cancer-selective oncolysis through intracellular DNA self-assembly.
• The developed technology offers a powerful new modality for cancer immune therapy with reduced systemic toxicity.
• Targeted activation of innate immunity via artificial nucleic acids represents a promising strategy for cancer treatment.